Díaz, F. P., Kurtz, D. M., Gregg, J., Coyne, Z., Khan, S., Feng, J., Waddell, T. K., Yasufuku, K., Donahoe, L., Pierre, A., Keshavjee, S., Yeung, J., Cypel, M., Perrot, M. D., Wakeam, E., Rabey, M. R., Le, L. W., Stowell, S. L., Diehn, M., Leighl, N. B. (2026). Ultrasensitive tumor-informed ctDNA MRD detection to identify metastatic relapse and as predictor of recurrence-free survival following resection of early-stage NSCLC.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.3060